Mike G.W. de Leeuw, MSc - Chief Executive Officer
Mike holds a masters degree (Leiden, 1985) in tumor virology and a bachelors in business administration from Rotterdam School of Management & IMD. His career with Unilever, Shell and DSM brought him to senior executive roles and general management positions in EU, China and India in Pharma, Polymers and Biomedical/drug delivery fields. As of 2008 Mike has founded, managed and consulted several start-ups in drug delivery (Branching Tree, InGell Labs, OncoLize) and in regenerative medicine (Beta Cell, Hy2Care, Isotis). He and his teams have initiated and raised over €120 million in private and public fundings for innovative drug delivery projects and companies. Mike's focus is on the strategy, structure and funding of the company.
Pieter Jan Vos, MSc – Chief Business Officer, co-founder
Pieter Jan received his M.Sc. in Chemistry from Leiden University and graduated from ESCP Europe, School of Management, Paris, France. Pieter Jan is former Director New Business Active Pharmaceutical Ingredients at Diosynth / Organon, Oss, The Netherlands. He subsequently founded Amspar BV, a company that focuses on global licensing of generic pharmaceuticals. Pieter Jan became involved in MyLife Technologies in co-founding the company in 2012. Pieter Jan focuses on partnerships with pharma- and biotech companies; outlicensing of the npMNA technology; and on obtaining non-dilutive funding through grants from NGO's and governmental programs.
Leo de Leede, PhD - Pharmacologist - Head of Pharmaceutical Development
Leo is a pharamacist by training (Leiden, 1984) and has a rich and highy recognized career in Biopharmaceutical drug delivery, ranging from Organon/MSD, Gist Brocades/DSM, Yamanuchi/Astellas, to Octoplus/Dr.Reddy's early clinical trial management. Leo established Exelion BioPharmaceutical consulting in 2008, and has been consulting multiple clients on their development tracks ever since, including InGell Labs and OncoLize. Leo manages the fit between client's active or vaccine and the program to combine this with our npMNA's.
Leonie de Best, MSc. - Head of Operations
Leonie has a Master's degree in analytical chemistry from Leiden University (1997). Her expert skills and experiences in translating concepts to working solutions of consistent quality has been honed in her previous positions with OctoPlus/Dr.Reddy, Kiadis, Skyline Diagnostics. With her consulting company B-liss she is involved in various start-ups including MyLife Technologies. Leonie manages the expansion of the activities in our labs and acertaining the quality of our output, while leading the lab team.
Koen van der Maaden, PhD – Scientific Advisor/ vaccine delivery
Koen obtained his bachelor degree in Pharmacy from Utrecht University in 2008 and completed his masters in Biopharmaceutical Sciences at Leiden University in 2010 with honors. In 2015 Koen obtained his PhD, Cum Laude, on Micro-Needle Mediated Vaccine Delivery; his thesis was elected Best Thesis 2015 of the Leiden University. Koen has become an internationally known specialist in microneedle research. Koen headed MLT’s scientific development from 2016 to 2019. He is actively collaborating with our company on vaccine delivery for both infectious diseases and for tumor eradication. He is advancing his academic carreer in immuno-oncology at Leiden University Medical center and Leiden Academic center for Drug Research.
Nico Kuijt, BSc – Research Analyst
Nico obtained a Bachelor degree in Analytical Chemistry from Hogeschool Leiden in 2011. In January 2012, he started as associate scientist at to-BBB, Leiden, The Netherlands, working on the development and analysis of liposomal drug formulations. In February 2015, he started as associate scientist at Janssen Biologics, Leiden, The Netherlands, working on the analysis of a variety of drug formulations. In June 2015, he started at MyLife Technologies as Research Analyst currently working on the development and analysis of various nanoporous microneedle array formulations.
Sanne Rol, BSc – Research Analyst
Sanne obtained a Bachelor degree in Analytical Chemistry from Hogeschool Leiden in 2019. Previously she worked as intern at MyLife Technologies and started as research analyst at MyLife Technologies in July 2019. Sanne is currently working on the formulation and delivery of API's with our npMNA's.
Regina Lüttge, PhD
Regina received her PhD from University of London, Imperial College, on Microsystems Technology in 2003. In her scientific profile as associate professor in the Microsystems Group, Mechanical Engineering department at Eindhoven University of Technology, she mainly works on microsystems for life-science applications with an emphasis on miniaturized cell culture disease models supported financially by the ERC. Previously during her career at University of Twente (UT), Regina contributed to the creation of med-tech startup Medimate B.V. Together with her research team at UT, she has laid the foundation for the business case for UT’s patented npMNA technology.
Henk Viëtor, M.D., PhD
Henk Viëtor is a medical doctor and scientists by training, specialized in clinical immunology, transfusion medicine and clinical genetics. His scientific results were published in numerous leading scientific journals including Nature. He is inventor on several patents.
Since he co-founded Drug Discovery Factory in 2000, he has been an active entrepreneur and co-founder of 10 Life Sciences start-up companies. He is also on the board of the Center for Translational Medicine.